BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu P, Xu H, Shi Y, Deng L, Chen X. Potential Molecular Mechanisms of Plantain in the Treatment of Gout and Hyperuricemia Based on Network Pharmacology. Evid Based Complement Alternat Med 2020;2020:3023127. [PMID: 33149752 DOI: 10.1155/2020/3023127] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
Number Citing Articles
1 Cheng X, Kong D, Li Y, Bian G, Li D. Screening of dual targeted inhibitors of 5-lipoxygenase and cyclooxygenase-2 from Oroxylum indicum by off-line two-dimensional liquid chromatography coupled with mass spectrometry. Industrial Crops and Products 2022;186:115243. [DOI: 10.1016/j.indcrop.2022.115243] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Geng YH, Yan JH, Han L, Chen Z, Tu SH, Zhang LQ, Song CD, Duan FY, Liu YF. Potential molecular mechanisms of Ermiao san in the treatment of hyperuricemia and gout based on network pharmacology with molecular docking. Medicine (Baltimore) 2022;101:e30525. [PMID: 36123941 DOI: 10.1097/MD.0000000000030525] [Reference Citation Analysis]
3 Yang F, Shi W, Wang L, Qin N, Wang C, Guo Y, Xu G, Fang J, Yu X, Ma Q. Lipidomics study of the therapeutic mechanism of Plantaginis Semen in potassium oxonate-induced hyperuricemia rat. BMC Complement Med Ther 2021;21:175. [PMID: 34172058 DOI: 10.1186/s12906-021-03350-x] [Cited by in F6Publishing: 3] [Reference Citation Analysis]